[ORGANIZATION]

Enhertu

Featured in 3 tracked stories · first seen 2 months ago

Situations

[ACTIVE] [BUSINESS] [US] [EU] [CN]

AstraZeneca regulatory and portfolio developments

3 clusters · 5 sources · last updated 2 days ago

Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments

AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE

[QUIET] [HEALTH] [CN] [JP] [KR]

Advancements in lung and breast cancer clinical trials

2 clusters · 13 sources · last updated 18 days ago

Latest: HER2-targeted antibody-drug conjugates show positive Phase III trial results

Recent clinical trial data presented at the IASLC 2026 World Conference on Lung Cancer and in the Journal of Clinical Oncology highlight significant advancements in oncology treatments, particularly regarding antibody-dr